Mayo Clinic Talks

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Alan H. Bryce, M.D. Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early, and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D., from the Division of Hematology and Oncology at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Nahid Punjani, M.D., M.P.H. Issues related to the prostate can play a significant role in a man’s sexual function. We commonly use medications for benign prostate problems such as BPH which can produce adverse effects. It’s also very common for the treatment of prostate cancer, whether we use radiation therapy, surgical prostatectomy, or hormonal therapy to cause sexual dysfunction. In this podcast, we’ll review the important role the prostate plays in sexual function as we discuss the “Prostate and Sexual Health” with our guest, Nahid Punjani, M.D., M.P.H., a urologist at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: R. Jeffrey Karnes, M.D. Prostate cancer is the most common solid organ malignancy in males, and it’s estimated that 1 in 8 men will develop prostate cancer during their lifetime.  When diagnosed early, it has an excellent survival rate with a variety of very effective treatment options. What are the advantages and disadvantages of each?  Why would one option be chosen over another and how do the adverse effects of the various treatments differ? In this podcast, I’ll be discussing these questions with our guest, R. Jeffrey Karnes, M.D., a urologist at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Daniel M. Frendl, M.D., Ph.D. Prostate cancer is one of the most common malignancies in men, second only to skin cancer. It’s estimated that 1 in 8 men will develop prostate cancer during their lifetime. The predominant screening test for prostate cancer has been the prostate specific antigen or PSA.  However, there has been some controversy surrounding the use of PSA. It’s an easily administered test, it’s relatively inexpensive and it’s capable of identifying men with possible prostate cancer. So, what’s the controversy? Is the PSA an effective screening test? Who should be tested and how have urologists modified their practice to manage patients with an elevated PSA? We’ll discuss these questions in today’s podcast on “Screening for Prostate Cancer” with our guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Mayo Clinic. This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.   

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Mitchell R. Humphreys, M.D. Benign prostatic hyperplasia or BPH is quite common in middle-age and older men. It’s estimated that up to 70% of men over age 60 have symptoms from BPH. While BPH is not a life-threatening condition, it does produce symptoms which can negatively affect the lifestyle of our patients. Since most of the patients with BPH are managed by primary care providers, we should be comfortable with the variety of treatment options available. When should treatment be initiated? What’s available pharmacologically? And when should a urologist be consulted to consider a surgical option? In this podcast, we’ll discuss these questions and more with Mitchell R. Humphreys, M.D., from the Department of Urology at the Mayo Clinic.  This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/ Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.   

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Colin P. West, M.D., Ph.D. The practice of medicine is often stressful and at times, even frustrating. Sometimes the stress and frustration can get out of hand and lead us to feeling overwhelmed and hopeless. This has been described as burnout. There’s good evidence to suggest that well over half of all physicians practicing in the U.S. have exhibited some symptoms of burnout at some time during their career. Healthcare professional burnout not only has negative consequences for the clinician, but also for patients, as patient care can often suffer. What are the symptoms of burnout, can we prevent them and how can we manage those who are experiencing professional burnout? We’ll discuss these questions and more with Colin P. West, M.D., Ph.D., an internist in the Division of General Internal Medicine at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Tara Schmidt, MEd, RDN, LD Nutrition is so important to our health. What and how much we eat can help keep us healthy or increase our risk of developing a number of health problems including cardiovascular disease, diabetes, malignancy or a variety of degenerative health conditions. Unfortunately, many of our patients obtain their information regarding nutrition from the media which is often very inaccurate. It’s our responsibility as primary care providers to assess our patients’ nutritional status and give them accurate recommendations regarding dietary changes they should make in order to remain healthy. This starts with a nutritional history. Yet very few of us have had any formal education in nutrition. How do we take a nutritional history? What are the important questions to ask? We’ll discuss this and other nutritional issues with our guest for this podcast, Tara Schmidt, MEd, RDN, LD, a registered dietician at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Thom W. Rooke, M.D. Today, we’re excited to bring back a special lecture by popular demand from Season 1 of Mayo Clinic Talks Podcast. We’ll be discussing varicose veins and venous insufficiency with Thom W. Rooke, M.D., from Cardiovascular Medicine at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Eoin Flanagan, M.B., B.Ch. Nearly 1 million individuals in the U.S. have multiple sclerosis. Most acquire the disease between the ages of 20 and 50. It’s often difficult to establish a diagnosis as the symptoms can be vague and often vary significantly from one individual to another.  The disease can be very frightening, often debilitating, and progressive; up until recently, we’ve had very little to offer patients in the way of treatment.  However, in the past few years there have been numerous advances in treatment options which have given hope to the many patients with MS. We’ll be discussing multiple sclerosis in this podcast. Our guest is Eoin Flanagan, M.B., B.Ch., a neurologist from the Department of Neurology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Andrew C. Storm, M.D. Determining the source of GI blood loss can be a challenging dilemma. On occasion, we have clues regarding where we should start looking, but in some cases, no such clues exist. It’s best to use a stepwise approach to determining the source and in most cases, this will give us the answer we need. When a cause is found, most tend to be from an upper GI source rather than the colon. Whereas an upper endoscopy and colonoscopy will determine the source in the majority, in some cases, more aggressive techniques are required. In this podcast, we’ll be discussing GI blood loss, and which approach we should use to determine the source. Our guest is Andrew C. Storm, M.D., a gastroenterologist from the Division of Gastroenterology and Hepatology at the Mayo Clinic. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.